Dxcover
2 known investors
Dxcover develops a multi-omic liquid biopsy platform that combines infrared light spectroscopy and machine learning to detect multiple cancers at an early stage. The platform is aimed at triaging high-risk populations for high-mortality cancers.
AI & Machine LearningBiotechMedical Devices